Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Associate Director, Market Access HTA, Spain is responsible for defining and executing the market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. Working closely with the Senior Director, Market Access HTA, in Spain, this role helps to shape business strategies, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities, both at national and regional level
The incumbent will partner with regional and global commercial, HEOR, and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursment dossiers and tools, engaging with market access and public affairs stakeholders as well as participating in pricing strategy activities, and drive the activities to deliver access results supporting the overall success of the product launches.
Responsibilities:
Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for oncology products within the Spanish healthcare system
HTA & Pricing Filings: Lead preparation and submission of value dossiers, and pricing negotiations with MoH and regional HTAs
Value Communication: Translate clinical and economic evidence into compelling value communications tailored for Spanish payers.
External Stakeholder Engagement: Build and maintain strong relationships with key external stakeholders (regional payers and policy maker authorities)
Identify and prioritize key stakeholders focus on HE with influence in HTAs process.
Effectively engages with HTA bodies and stakeholders like Regional HTAs, Physicians, Pharmacist and others identify as relevant.
Cross-Functional Collaboration: Work with Global and EU Region Market Access teams to align local access strategy with broader European and corporate objectives, especially in terms of aligning the European regulatory and JCA strategy and execution with local value dossier submission and pricing negotiation strategies
Participation in negotiations with all levels of national and regional payers
Collaborate with internal functions to develop innovative pricing and value based contracting models to optimize the acceleration of reimbursement approvals
Policy Monitoring: Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy
Drive access and value related projects such as landscape assessments, payer market research, payer advidory boards and general guidance on local strategies
Development of outreach and engagement plan for key payers and their influencers creating and maintaining a strong network
Participate in early access planning of new products and indications, drive launch readiness for multiple oncology assets
Market Access in Field base Support:
Maintain an up-to-date understanding of customer perspectives through regular engagement with payers (e.g. in-field visits).
Provide in field market access team with materials, strategies and tactics aligned with Strategic Objectives of the Brand & Value and Market Access.
Continuous up-date on brand strategies and tactics that could impact in the time and conditions to access to the market all Oncology products.
Participate in the elaboration and execution Value and Market Access Strategic and Tactical Plan aligned with Brand Team and field team: access, sales and marketing and medical affairs
Play an active role in the Brand Team, providing input for the HEOR & Pricing Manager and field access team and identify opportunities to work collaboratively with cross-functional colleagues to deliver on brand objectives and provide training of analysis, tools, evidence, actions and programs to support and communicate the value proposition.
Complies with all laws, regulations and policies that govern the conduct of Revolution Medicines staff.
Visibly embodies corporate Core Values while cultivating an energized team culture focused on patient impact
Required Skills, Experience and Education:
Advanced degree (e.g., PhD in Life Sciences, Pharmacy, Health Economics, Public Health)
10+ years experience in market access, pricing, reimbursement or health economics (pharma/biotech/market access consulting)
Experience of involvement in HTA submissions with at least 1 recent HTA submission (within last 12 months). In-depth HEOR technical expertise and experience
Demonstrated success and experience supporting a oncology product pre-launch, launch and post launch in Spain
Demonstrated succces in negotiating pricing and reimbursement conditions with public administrations and health authorities
Strong stakeholder management and ability to collaborate with internal and external partners
Excellent communication skills, both in person and virtual
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments
Strong commercial and strategic acumen
Willingness to travel nationally and internationally
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
#LI-JM1 #LI-Remote
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Skills Required
- Advanced degree such as a PhD in Life Sciences, Pharmacy, Health Economics, or Public Health
- 8+ years of experience in market access, pricing, reimbursement, or health economics within pharma, biotech, or market access consulting
- Proven AMNOG and benefit assessment experience
- Deep understanding of payer decision-making in Germany
- Successful experience supporting an oncology product through pre-launch, launch, and post-launch in Germany
- Experience negotiating pricing and reimbursement conditions with public administrations and health authorities
- Strong stakeholder management and collaboration skills
- Excellent in-person and virtual communication skills
- Scientific, solution-oriented mindset and ability to execute in a rapidly changing environment
- Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments
- Strong commercial and strategic acumen
- Willingness to travel nationally and internationally
- Proven leadership and people management capabilities
- Success in a small, fast-growing, entrepreneurial commercial environment
What We Do
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses
